Orsolya Kolacsek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Orsolya Kolacsek has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anita Schamberger
Membrane Research Group of the Hungarian Academy of Sciences, Semmelweis University and National Blood Center, Budapest, Hungary
2 shared publications - Balázs Sarkadi
Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Magyar Tudosok krt. 2, 1117 Budapest, Hungary
2 shared publications - György Várady
Membrane Research Group of the Hungarian Academy of Sciences, Semmelweis University and National Blood Center, Budapest, Hungary
2 shared publications - Lajos Mátés
Mobile DNA Group, Max-Delbrück Center for Molecular Medicine, Berlin, Germany
2 shared publications - Tamás István Orbán
Gene Regulation Research Group, Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary
2 shared publications - Virág Krízsik
Membrane Research Group of the Hungarian Academy of Sciences, Semmelweis University and National Blood Center, Budapest, Hungary
2 shared publications
Latest Publications
- Open Access
- 15 March 2013
- Published by Springer Nature in Mobile DNA
- Vol. 4 (1) , 11
Erratum to: Reliable transgene-independent method for determining sleeping beauty transposon copy numbers
- 15 March 2013
- Published by Springer Nature in Mobile DNA
- Vol. 4 (1) , 11
Open AccessErratum to: Reliable transgene-independent method for determining sleeping beauty transposon copy numbers
- Open Access
- 3 March 2011
- Published by Springer Nature in Mobile DNA
- Vol. 2 (1) , 5
Reliable transgene-independent method for determining Sleeping Beauty transposon copy numbers
Background: The transposon-based gene delivery technique is emerging as a method of choice for gene therapy. The Sleeping Beauty (SB) system has become one of the most favored methods, because of its efficiency and its random integration profile. Copy-number determination of the delivered transgene is a crucial task, but a universal method for measuring this is lacking. In this paper, we show that a real-time quantitative PCR-based, transgene-independent (qPCR-TI) method is able to determine SB transposon copy numbers regardless of the genetic cargo. Results: We designed a specific PCR assay to amplify the left inverted repeat-direct repeat region of SB, and used it together with the single-copy control gene RPPH1 and a reference genomic DNA of known copy number. The qPCR-TI method allowed rapid and accurate determination of SB transposon copy numbers in various cell types, including human embryonic stem cells. We also found that this sensitive, rapid, highly reproducible and non-radioactive method is just as accurate and reliable as the widely used blotting techniques or the transposon display method. Because the assay is specific for the inverted repeat region of the transposon, it could be used in any system where the SB transposon is the genetic vehicle. Conclusions: We have developed a transgene-independent method to determine copy numbers of transgenes delivered by the SB transposon system. The technique is based on a quantitative real-time PCR detection method, offering a sensitive, non-radioactive, rapid and accurate approach, which has a potential to be used for gene therapy.
- 3 March 2011
- Published by Springer Nature in Mobile DNA
- Vol. 2 (1) , 5
Open AccessReliable transgene-independent method for determining Sleeping Beauty transposon copy numbers
Background: The transposon-based gene delivery technique is emerging as a method of choice for gene therapy. The Sleeping Beauty (SB) system has become one of the most favored methods, because of its efficiency and its random integration profile. Copy-number determination of the delivered transgene is a crucial task, but a universal method for measuring this is lacking. In this paper, we show that a real-time quantitative PCR-based, transgene-independent (qPCR-TI) method is able to determine SB transposon copy numbers regardless of the genetic cargo. Results: We designed a specific PCR assay to amplify the left inverted repeat-direct repeat region of SB, and used it together with the single-copy control gene RPPH1 and a reference genomic DNA of known copy number. The qPCR-TI method allowed rapid and accurate determination of SB transposon copy numbers in various cell types, including human embryonic stem cells. We also found that this sensitive, rapid, highly reproducible and non-radioactive method is just as accurate and reliable as the widely used blotting techniques or the transposon display method. Because the assay is specific for the inverted repeat region of the transposon, it could be used in any system where the SB transposon is the genetic vehicle. Conclusions: We have developed a transgene-independent method to determine copy numbers of transgenes delivered by the SB transposon system. The technique is based on a quantitative real-time PCR detection method, offering a sensitive, non-radioactive, rapid and accurate approach, which has a potential to be used for gene therapy.